Timing of heart failure development and clinical outcomes in patients with acute myocardial infarction

Hyung Yoon Kim(Chonnam National University), Jeong Gwan Cho(Chonnam National University Hospital), Kye Hun Kim(Chonnam National University), Jae Yeong Cho(Chonnam National University Hospital), Youngkeun Ahn(Chonnam National University Hospital), Hyukjin Park(Chonnam National University Hwasun Hospital), Hyun Ju Yoon(Chonnam National University Hospital), Myung Ho Jeong(Veterans Health Service Medical Center), Nuri Lee(Chonnam National University Hospital)
Frontiers in Cardiovascular Medicine
June 30, 2023
10.3389/fcvm.2023.1193973
Cited by 7

Related Papers

Mesenchymal stem cells reciprocally regulate the M1/M2 balance in mouse bone marrow-derived macrophages
|Experimental & Molecular Medicine|2014|548
Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion
|Circulation|2019|398
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial
|The Lancet|2021|202
Circadian rhythm of hyperoxidized peroxiredoxin II is determined by hemoglobin autoxidation and the 20S proteasome in red blood cells
|Proceedings of the National Academy of Sciences|2014|132
Characteristics, Outcomes, and Treatment of Heart Failure With Improved Ejection Fraction
|Journal of the American Heart Association|2019|113